| Bioactivity | Kallikrein 5-IN-2 (compound 21) is a selective Kallikrein KLK5 inhibitor (pIC50=7.1). KLK5 inhibition may normalise epidermal shedding and reduce the associated inflammation and itching[1]. |
| Target | Kallikrein 5 |
| Name | Kallikrein 5-IN-2 |
| CAS | 2361160-57-6 |
| Formula | C23H22N6O |
| Molar Mass | 398.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Walker AL, et al. Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome. Bioorg Med Chem Lett. 2019 Jun 15;29(12):1454-1458. |
Kallikrein 5-IN-2
CAS: 2361160-57-6 F: C23H22N6O W: 398.46
Kallikrein 5-IN-2 (compound 21) is a selective Kallikrein KLK5 inhibitor (pIC50=7.1). KLK5 inhibition may normalise epid
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.